株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

治験用品およびロジスティクス:世界市場の展望

Clinical Trial Supply and Logistics for Pharma 2016-2026: Analysis of Manufacturing, Packaging, Cold Chain and Supply Chain Management

発行 Visiongain Ltd 商品コード 286489
出版日 ページ情報 英文 206 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1GBP=147.86円で換算しております。

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[?]アイコンをクリックしてご確認ください。

Back to Top
治験用品およびロジスティクス:世界市場の展望 Clinical Trial Supply and Logistics for Pharma 2016-2026: Analysis of Manufacturing, Packaging, Cold Chain and Supply Chain Management
出版日: 2016年03月02日 ページ情報: 英文 206 Pages
概要

世界の治験サポート市場は、2015年から2025年に安定して成長し、2018年には154億米ドルの規模に達することが見込まれています。

当レポートでは、世界の治験用品およびロジスティクス市場を取り上げ、製造、ロジスティクスおよび販売、ならびにサプライチェーン管理サブマーケットを概括し、主要国市場の展望、主要地域における規制の動向、ならびに産業動向をまとめ、コールドチェーンロジスティクスに関する分析を行うとともに、主要企業のプロファイルをまとめ、お届けいたします。

第1章 調査概要

第2章 治験用品およびロジスティクス市場の定義

第3章 世界市場の展望と予測

  • 世界の治験用品およびロジスティクス市場
  • 世界の治験用品およびロジスティクス市場の予測
  • 治験製造サブマーケット
  • 治験ロジスティクスおよび販売サブマーケット
  • 治験サプライチェーン管理サブマーケット

第4章 主要国における治験用品およびロジスティクス市場

  • 治験用品およびロジスティクスの主要国サブマーケットの定義
  • 治験用品およびロジスティクスの主要国サブマーケット
  • 米国における治験用品およびロジスティクス市場
  • 西欧
  • 日本:アウトソースロジスティクスにおける新たな成長市場
  • 新興市場における治験用品
  • ラテンアメリカにおける治験用品およびロジスティクス市場
  • ロシアと中東欧(CEE)
  • インド:治験の新たなアウトソース先
  • 中国における治験用品およびロジスティクス市場

第5章 治験用品およびロジスティクス:規制の展望

  • 規制基準は治験用品にどのような影響を及ぼすのか
  • 米国における治験用品規制
  • EUにおける治験用品規制
  • 日本における薬剤のGMP(製造管理および品質管理基準)および輸入規制
  • 新興市場における治験サプライチェーン

第6章 治験用品およびロジスティクス:産業動向

  • 治験用品およびロジスティクス市場:強みと弱み
  • 治験用品およびロジスティクス市場:機会と脅威
  • 治験用品およびロジスティクス市場:STEP分析
  • 治験サプライチェーンの確保
  • 治験の国際化は用品およびロジスティクスにどのような影響を及ぼすか?
  • 治験製造業の動向
  • 治験サプライチェーン管理動向
  • 治験用品およびロジスティクスのアウトソーシング

第7章 治験におけるコールドチェーンロジスティクスの台頭

  • コールドチェーン用品および販売のイントロダクション
  • コールドチェーンロジスティクスに関わる規制の展望
  • コールドチェーンが治験ロジスティクスに占める割合は増加する
  • 臨床コールドチェーンロジスティクスにおける技術の役割

第8章 治験用品およびロジスティクス市場:主要企業

  • サードパーティーロジスティクスプロバイダー:主要な臨床販売業者
    • World Courier:薬剤用品の専門家
    • DHL:サプライチェーンロジスティクスにおける世界的なリーダー
    • Marken
    • 市場におけるその他の主要な新興企業
  • 治験製造業者:サブマーケットのリーダー
    • Catalent Pharma Solutions
    • Patheon
    • Almac Group:製造、パッケージングおよびロジスティクスサービス
  • 治験用品およびロジスティクス市場におけるCROの役割
    • Parexel International
  • 治験用品およびロジスティクス市場におけるその他の主要な企業
    • Fisher Clinical Services (FCS)
    • Packaging Coordinators Inc. (PCI)

第9章 調査インタビュー

第10章 結論

  • 治験用品およびロジスティクス市場
  • 市場の展望
  • 新興市場における臨床ロジスティクスに対する需要の拡大
  • 技術および革新がアウトソーシングを促進

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: PHA0095

Supporting clinical trials - discover that industry's latest trends, news and revenue potentials

What are the prospects for supplying and assisting medical testing? Now you can get revenue forecasts for that market, data helping you stay ahead. Discover financial prospects. And explore pharmaceutical R&D trends, technologies, clients' needs and opportunities.

Visiongain's updated report gives you revenue forecasts to 2025 at overall world market, submarket and national level. Examine the high value and potential those pharmaceutical contracting services hold. And there assess technology, results and expected sales.

So what are the secrets of that industry's future success? Please read on to explore clinical trial supply and logistics, also discovering, below, that industry's potential future revenue.

Forecasting from 2015 and other analysis to help you stay ahead in business information

Besides revenue forecasting to 2025, our new work shows recent results, growth rates and market shares. There you find original analyses. Also investigate healthcare research and development needs. You gain 55 tables, 58 charts and four interviews with companies.

Our new report shows you what the future holds for pharmaceutical contract research organisations (CROs) and manufacturing contractors (CMOs) supplying products and logistics services for clinical trials.

You also explore specialists in logistical support, including cold chain distribution. See, too, progress and implications for drug developers, clinical trial sponsors and organisers.

The purpose of that analysis is to give business predictions that planners, influencers and leaders need. And the following sections explain how that investigation helps you.

Revenues for the clinical trial supply and distribution market and its segments

Along with prediction of the overall world market for those developmental services, our study shows you individual sales predictions for seven submarkets of clinical trial support at world level to 2025:

  • Manufacturing - also with forecasts for packaging and for other production
  • Logistics and distribution - also with forecasts for cold chain logistics and for other services
  • Supply chain management.

Why struggle to find data? Why miss information you need? Instead let our analysis guide you through that healthcare outsourcing industry's present and future, making work easier.

Our report gives you feel for what stimulates and restrains that industry and market. There you identify potential in those technologies and services. See, then, where progress and money lie. Success in business relies on the latest industry knowledge and predictions.

Also find geographical sales projections.

National markets - what outlooks for service demand and provision?

There our analyses show you individual revenue forecasts to 2025 for 11 national markets:

  • The United States (US)
  • Japan
  • EU5 countries - Germany, France, the UK, Italy and Spain
  • BRIC nations - Brazil, Russia, India and China.

For those service providers and clients, many opportunities exist in developed and developing countries. Expanding pharma R&D worldwide will influence that market for outsourced services. Discover in our study how you and your organisation can benefit.

Having that analysis could bring you quicker, easier decisions and results. That way you can benefit in planning and authority on the supply and logistical needs of clinical testing.

There examine the present and future. In particular, our work explains commercial issues.

Developments, challenges and opportunities affecting CROs, CMOs and related companies

The report explains what affects that industry and market from 2015, including these forces:

  • Regulatory standards for clinical trial supply and organisation, inc. good manufacturing practice (GMP) and good distribution practice (GDP)
  • Globalisation - access to new markets and patients, and its effects
  • Supply chain security and other technology for developing and testing medicines
  • Biologics (biological drugs) and other complex therapies
  • Trends in packaging for clinical testing
  • Management of multiple supplier networks.

And also these influences:

  • Cold chain logistics for testing complex drug products, including reusable cold chain packaging and RFID use for temperature monitoring
  • Forecasting and demand modelling to ensure supply
  • IT systems for clinical trial planning: IVRS and IWRS
  • Adaptive clinical trials - how they affect supply and logistical needs
  • Home-based trial participation - challenges and opportunities for that industry.

So you explore strengths, weaknesses, opportunities and threats (SWOT), as well as political, economic, social, and technological questions (STEP), assessing outlooks for that trade.

See there what the future holds.

Organisations leading that pharma outsourcing industry and its overall 2018 revenue

What's possible for that industry? Our report predicts the world market for that clinical trial support will reach $15.4bn in 2018, with strong expansion from 2015 to 2025.

That work also shows technologies and companies holding greatest potential. In particular, explore activities of these firms, hearing what they've achieved and where they head:

  • Catalent Pharma Solutions
  • Patheon
  • Almac Group
  • Parexel International
  • Fisher Clinical Services
  • Movianto

Our study also assesses these service providers, among other organisations:

  • World Courier
  • DHL
  • Marken
  • TNT Express
  • FedEx

Also read interviews with four authorities from the industry. Hear what participants think, say and do, helping you stay ahead. So benefit your influence and reputation for insight.

There avoid falling behind. Instead find where progress, potential and money exist, getting information for commercial success.

Ways Clinical Trial Supply and Logistics: World Industry and Market Outlook 2015-2025 helps

In five main ways our new study benefits your research, analysis and knowledge:

  • See revenues possible from 2015 to 2025 in that overall world market and 7 submarkets, as well as 11 top national markets in the Americas, Europe and Asia.
  • Explore regulations and their effects in regional and national markets in 2014, also assessing trends and prospects from 2015.
  • Examine service and drug development issues affecting that outsourcing market's participants and their clients from 2015, also getting SWOT and STEP analyses.
  • Assess prospects for established, emerging and rising service providers, exploring portfolios, results, deals, technologies and progress.
  • Gather insight on the present and future from authorities on clinical trial supply and logistics, including opinion from our survey's four interviews with prominent firms.

However knowledgeable you are, benefit now from our forecasting, discussions and interviewing. Those methods our analysts have refined and extended for more than 10 years, providing healthcare analyses to explain opportunities and potential revenues.

That way stay ahead, getting predictions top companies depend on again and again.

Potentials for clinical trial supplying and distributing - discover from 2015 what's possible

In our new report you receive competitive intelligence found only in that work, seeing where money, progress and opportunities exist, now and in future.

That way you're less likely to miss opportunity or fall behind. Instead stay ahead for commercial and technological knowledge. There explore trends, progress and revenue predications. So please get that new investigation here now.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Overview of the World Market Clinical Trial Supply and Logistics
  • 1.2. Why You Should Read This Report
  • 1.3. How This Report Delivers
  • 1.4. Main Questions Answered by this Analysis
  • 1.5. Who Is This Study For?
  • 1.6. Methods of Research and Analysis
  • 1.7. Frequently Asked Questions (FAQs)
  • 1.8. Some Associated Reports
  • 1.9. About Visiongain

2. Defining the Clinical Trial Supply and Logistics Market

  • 2.1. An Introduction to the Clinical Trial Supply and Logistics Market
  • 2.2. Clinical Trials are Becoming Increasingly Complex
  • 2.3. Clinical Trial Globalisation: Access to New Markets and New Patients
  • 2.4. Outsourcing Clinical Trial Supply and Logistics
  • 2.5. What Services Are Most Commonly Outsourced?
  • 2.6. Which Companies Participate in the Clinical Trial Supply and Logistics Market?
  • 2.7. Clinical Trial Supply and Logistics: Trends and Future Outlook

3. Clinical Trial Supply and Logistics: World Market Outlook and Forecasting 2015-2025

  • 3.1. The World Clinical Trial Supply and Logistics Market 2013
    • 3.1.1. Which Were the Leading Market Sectors in 2013?
  • 3.2. The World Clinical Trial Supply and Logistics Market Forecast 2015-2025
    • 3.2.1. What Will Drive Market Growth to 2025?
    • 3.2.2. Clinical Trial Supply and Logistics: Market Restraints 2015-2025
  • 3.3. Clinical Trial Manufacturing Submarket 2015-2025
    • 3.3.1. Outlook and Forecast for the Clinical Trial Manufacturing Submarket 2015-2025
    • 3.3.2. Complex Manufacturing and Packaging to Drive Growth 2015-2025
    • 3.3.3. Clinical Trial Packaging Submarket Forecast 2015-2025
  • 3.4. Clinical Trial Logistics and Distribution Submarket 2015-2025
    • 3.4.1. Clinical Trial Logistics and Distribution Submarket Forecast 2015-2025
    • 3.4.2. Submarket Drivers and Restraints 2015-2025
    • 3.4.3. Clinical Trial Cold Chain Distribution Submarket Forecast 2015-2025
  • 3.5. Clinical Trial Supply Chain Management Submarket 2015-2025
    • 3.5.1. Clinical Trial Supply Chain Management Submarket Forecast 2015-2025
    • 3.5.2. Drivers and Restraints for the Clinical Trial Supply Chain Management Submarket 2015-2025

4. Leading National Markets for Clinical Trial Supply and Logistics 2015-2025

  • 4.1. Defining National Submarkets for Clinical Trial Supply and Logistics
  • 4.2. Leading National Submarkets for Clinical Trial Supply and Logistics 2013
    • 4.2.1. How Will These Leading Submarkets Grow 2015-2025?
  • 4.3. Clinical Trial Supply and Logistics in the US 2015-2025
    • 4.3.1. How Will Demand for Clinical Trial Logistics Grow in the US to 2025?
  • 4.4. Western Europe
    • 4.4.1. Western Europe: Clinical Trial Supply and Logistics Submarket Forecast 2015-2025
    • 4.4.2. The EU5: National Submarket Forecasts 2015-2025
  • 4.5. Japan: A New and Growing Market for Outsourced Logistics
    • 4.5.1. Japanese Clinical Trial Supply and Logistics Submarket Forecast 2015-2025
  • 4.6. Clinical Trial Supply in Emerging National Markets
  • 4.7. The Latin American Clinical Trial Supply and Logistics Market 2015-2025
    • 4.7.1. Challenging Distribution Conditions
    • 4.7.2. Brazilian Clinical Trial Supply and Logistics Submarket Forecast 2015-2025
  • 4.8. Russia and Central and Eastern Europe (CEE)
    • 4.8.1. Outsourcing Will Grow Strongly in Russia
    • 4.8.2. Russian Clinical Trial Supply and Logistics Submarket Forecast 2015-2025
  • 4.9. India: An Emerging Destination for Outsourced Clinical Trials
    • 4.9.1. New Clinical Trial Rules Restrain Growth in 2013
    • 4.9.2. Indian Clinical Trial Supply and Logistics Submarket Forecast 2015-2025
  • 4.10. Clinical Trial Supply and Logistics in China 2015-2025
    • 4.10.1. Foreign Investment in Chinese Clinical Trial Logistics
    • 4.10.2. Strong Growth for Clinical Trial Supply and Logistics in China 2015-2025

5. Clinical Trial Supply and Logistics: Regulatory Outlook 2015-2025

  • 5.1. How do Regulatory Standards Affect Clinical Trial Supply?
    • 5.1.1. Good Practices (GxP) in Clinical Trial Distribution
      • 5.1.1.1. Good Manufacturing Practice (GMP)
      • 5.1.1.2. Good Distribution Practice (GDP)
    • 5.1.2. Import Regulations Complicate International Manufacturing and Trials
  • 5.2. Clinical Trial Supply Regulations in the US 2013
    • 5.2.1. Importing Drugs into the US: A Reinterpretation of the Rules
  • 5.3. Clinical Trial Regulations in the EU 2013
    • 5.3.1. Manufacturing Requirements for Clinical Trial Materials in the EU
    • 5.3.2. The European Commission Releases New GDP Guidelines 2013
  • 5.4. GMP and Importation Regulations for Pharmaceuticals in Japan 2013
  • 5.5. Clinical Trial Supply Chain Regulations in Emerging Markets
    • 5.5.1. China: Tougher Regulations for Pharmaceutical Companies and Service Providers
      • 5.5.1.1. Improving Supply Chain Security in China 2013
    • 5.5.2. India: Drug Manufacturing and Imports for Clinical Trials
      • 5.5.2.1. The CDSCO Drafts New GDP Guidelines 2013
    • 5.5.3. Brazil: Slow Regulatory Approval for Clinical Trials
    • 5.5.4. Recent Updates to Pharmaceutical Regulation in Russia

6. Clinical Trial Supply and Logistics: Industry Trends 2015-2025

  • 6.1. Clinical Trial Supply and Logistics Market: Strengths and Weaknesses 2013
  • 6.2. Clinical Trial Supply and Logistics Market: Opportunities and Threats 2015-2025
  • 6.3. Clinical Trial Supply and Logistics Market: STEP Analysis 2015-2025
    • 6.3.1. Social Factors
    • 6.3.2. How Will Novel Technologies Affect the Market to 2025?
    • 6.3.3. Economic Pressures: Demands for Lower Cost Trials and Logistics
    • 6.3.4. Political Issues
  • 6.4. Securing the Clinical Trial Supply Chain 2015-2025
    • 6.4.1. How Will Technology Improve Supply Chain Security?
  • 6.5. How Will Clinical Trial Globalisation Impact Supply and Logistics?
  • 6.6. Trends in Clinical Trial Manufacturing 2015-2025
    • 6.6.1. The Challenge of Comparator Sourcing for Clinical Trials
      • 6.6.1.1. Comparators Are a Source of Risk for Supply Chain Security
      • 6.6.1.2. Regulators and Payers Will Increasingly Demand Comparative Effectiveness Research
    • 6.6.2. Trends in Packaging for Clinical Trials 2015-2025
  • 6.7. Clinical Trial Supply Chain Management Trends to 2025
    • 6.7.1. Forecasting and Modelling to Ensure Sufficient Supply
    • 6.7.2. IT Systems Improve Clinical Trial Planning: IVRS and IWRS
    • 6.7.3. Home-Based Trial Participation: Opportunities and Challenges for Logistics
    • 6.7.4. How Will Greater Use of Adaptive Clinical Trials Impact Trial Logistics?
  • 6.8. Outsourcing Clinical Trial Supply and Logistics
    • 6.8.1. Managing Multiple Supplier Networks

7. The Rise of Cold Chain Logistics in Clinical Trials 2015-2025

  • 7.1. An Introduction to Cold Chain Supply and Distribution
    • 7.1.1. The Importance of Cold Chain for Clinical Trials
    • 7.1.2. Maintaining the Cold Chain
  • 7.2. The Regulatory Outlook for Cold Chain Logistics
    • 7.2.1. International Air Transport Regulations and Guidance: The Temperature Sensitive Label
  • 7.3. Cold Chain Will Account for an Increasing Proportion of Clinical Trial Logistics 2015-2025
    • 7.3.1. Biologic Drug Development Will Stimulate Demand
      • 7.3.1.1. Emerging Trends in Biological Drug Development
    • 7.3.2. Pharma Cold Chain Logistics in Emerging Markets
  • 7.4. The Role of Technology in Clinical Cold Chain Logistics
    • 7.4.1. Active and Passive Temperature Control
    • 7.4.2. There Are Many Ways to Maintain Temperature in the Cold Chain
      • 7.4.2.1. Developments in Phase Change Materials
      • 7.4.2.2. The Benefits of Liquid Nitrogen for Sample Transportation
    • 7.4.3. Advances in RFID for Temperature Monitoring
      • 7.4.3.1. Will Uptake for RFID Grow Among Biopharma Companies to 2025?
    • 7.4.4. Future Technologies for Cold Chain Supply Management
      • 7.4.4.1. Demand for Reusable Cold Chain Packaging

8. Clinical Trial Supply and Logistics Market: Leading Companies

  • 8.1. Third Party Logistics Providers: Leading Clinical Distributors
    • 8.1.1. World Courier: A Pharmaceutical Supply Specialist
      • 8.1.1.1. Distribution Services for Pharma, CROs and Central Laboratories
      • 8.1.1.2. World Courier Is the Clinical Trial Distribution Market Leader
      • 8.1.1.3. World Courier Opens New Service Depots in Europe and Latin America 2013
    • 8.1.2. DHL: A Global Leader in Supply Chain Logistics
      • 8.1.2.1. Life Sciences: A Fast-Growing Source of Revenue for DHL Supply Chain
      • 8.1.2.2. DHL Adds New Services for Healthcare and Clinical Trial Clients 2013
    • 8.1.3. Marken
      • 8.1.3.1. What Services Does Marken Offer Clinical Trial Sponsors?
      • 8.1.3.2. Marken: Challenging Market Conditions 2009-2013
      • 8.1.3.3. Marken Continues to Expand Worldwide
      • 8.1.3.4. Expertise in Biological Sample Management
    • 8.1.4. Other Leading and Emerging Players in the Market
      • 8.1.4.1. TNT Express
      • 8.1.4.2. FedEx
      • 8.1.4.3. Movianto - a European Healthcare Specialist
  • 8.2. Clinical Trial Manufacturing: Submarket Leaders
    • 8.2.1. Catalent Pharma Solutions
      • 8.2.1.1. Clinical Trial Manufacturing and Supply Services
      • 8.2.1.2. Strong Growth for Clinical Manufacturing Revenue
      • 8.2.1.3. Catalent Increases its Focus on Clinical Trial Manufacturing
    • 8.2.2. Patheon
      • 8.2.2.1. Patheon Is a Leader in Pharmaceutical Development Services
      • 8.2.2.2. Patheon Completed 445 Clinical Projects in 2013
    • 8.2.3. Almac Group: Manufacturing, Packaging and Logistics Services
      • 8.2.3.1. Clinical Trial Supply and Management Solutions
      • 8.2.3.2. Almac Opens New Facilities to Expand its Clinical Trial Expertise
  • 8.3. The Role of CROs in the Clinical Trial Supply and Logistics Market
    • 8.3.1. Parexel International
      • 8.3.1.1. Parexel's Clinical Trial Supply and Logistics Services
      • 8.3.1.2. Parexel Expands Worldwide
  • 8.4. Other Leading Companies in the Clinical Trial Supply and Logistics Market 2013
    • 8.4.1. Fisher Clinical Services (FCS)
      • 8.4.1.1. FCS Offers Manufacturing, Packaging, Storage and Distribution Services
      • 8.4.1.2. Fisher BioServices: Clinical Logistics for the Cell Therapy Industry
    • 8.4.2. Packaging Coordinators Inc. (PCI)

9. Research Interviews from Our Survey

  • 9.1. Dr Pramod Kabra, General Manager and Managing Director, Fisher Clinical Services, India
    • 9.1.1. Fisher Clinical Services
    • 9.1.2. Trends in the Indian Clinical Research Market
    • 9.1.3. Why India Is an Attractive Site for Drug Development
    • 9.1.4. Challenges in Supply and Logistics in India
    • 9.1.5. Addressing the Risk of Counterfeiting
    • 9.1.6. Optimizing Cold Chain Services
    • 9.1.7. Feasibility of Direct-to-Patient Distribution in India
    • 9.1.8. Overcoming Regulatory Hurdles
    • 9.1.9. Forward-Looking Statement
  • 9.2. Ariette van Strien, Senior VP Commercial Operations, Marken, US
    • 9.2.1. Marken
    • 9.2.2. The Landscape of Emerging Markets
    • 9.2.3. Increasing Trend Towards Direct-to-Patient Distribution
    • 9.2.4. Expansion of Marken's Network
    • 9.2.5. Major Changes in This Decade
  • 9.3. Partha Chatterjee, Global Head, Clinical Research and Clinical Trial Supplies Management, SIRO Clinpharm
    • 9.3.1. SIRO Clinpharm
    • 9.3.2. Clinical Trial Supply Management
    • 9.3.3. SIRO Clinpharm's New Office in Hyderabad
    • 9.3.4. Challenges to be Addressed
    • 9.3.5. On SIRO Clinpharm's Services and Strengths
  • 9.4. Ramesh J. Chougule. Partner and AVP - Management Consulting, LifeScience, Infosys
    • 9.4.1. Infosys
    • 9.4.2. Contribution from the Life Sciences Sector
    • 9.4.3. Penetration of the Global Market
    • 9.4.4. Challenges in Emerging Markets
    • 9.4.5. How Will the Market Change in Five Years?

10. Conclusions of Our Study

  • 10.1. The Clinical Trial Supply and Logistics Market 2013
  • 10.2. Outlook for the Market 2014-2025
  • 10.3. Growing Demand for Clinical Logistics in Emerging Countries
  • 10.4. Technology and Innovation to Drive Outsourcing

List of Tables

  • Table 1.1: Clinical Trial Supply and Logistics Market: Overall Market and Revenue Forecasts by Sector ($bn), 2015-2025
  • Table 1.2: Currency Exchange Rates
  • Table 2.1: Clinical Trials Registered by Country/Region, 2014
  • Table 3.1: R&D Outsourcing Market: Revenue ($bn) and Market Share (%) by Sector, 2013
  • Table 3.2: Clinical Trial Supply and Logistics Market: Revenue ($bn) and Market Share (%) by Sector, 2013
  • Table 3.3: Clinical Trial Supply and Logistics Market: Overall Market and Revenue Forecasts by Sector ($bn), 2015-2025
  • Table 3.4: Clinical Trial Supply and Logistics Market: Submarket Shares (%), 2015-2025
  • Table 3.5: Clinical Trial Manufacturing Submarket: Revenue ($bn) and Submarket Share (%) by Sector, 2013
  • Table 3.6: Clinical Trial Manufacturing Submarket: Overall Submarket and Revenue Forecasts by Sector ($bn), 2013-2025
  • Table 3.7: Clinical Trial Packaging Submarket Forecast ($bn), 2015-2025
  • Table 3.8: Clinical Trial Logistics and Distribution Submarket: Revenue ($bn) and Submarket Share (%) by Sector, 2013
  • Table 3.9: Clinical Trial Logistics and Distribution Submarket: Overall Submarket and Revenue Forecasts by Sector ($bn), 2015-2025
  • Table 3.10: Clinical Trial Cold Chain Logistics Submarket Forecast ($bn), 2015-2025
  • Table 3.11: Clinical Trial Supply Chain Management Submarket Forecast ($bn), 2015-2025
  • Table 4.1: Clinical Trial Supply and Logistics Market: Revenues ($bn) and Market Shares (%) by Country/Region, 2013
  • Table 4.2: Clinical Trial Supply and Logistics Market: Regional and National Submarket Revenue Forecasts ($bn), 2015-2025
  • Table 4.3: Clinical Trial Supply and Logistics Market: Regional and National Submarket Shares (%), 2015-2025
  • Table 4.4: US Clinical Trial Supply and Logistics: Submarket Forecast ($bn), 2015-2025
  • Table 4.5: Western European Clinical Trial Supply and Logistics: Submarket Forecast ($bn), 2015-2025
  • Table 4.6: Western European Clinical Trial Supply and Logistics Submarket: Revenues ($bn) and Market Shares (%) by Top Country, 2013
  • Table 4.7: Western European Clinical Trial Supply and Logistics Submarket: Overall Forecast ($bn), 2015-2025
  • Table 4.8: German Clinical Trial Supply and Logistics: Submarket Forecast ($bn), 2015-2025
  • Table 4.9: French Clinical Trial Supply and Logistics: Submarket Forecast ($bn), 2015-2025
  • Table 4.10: UK Clinical Trial Supply and Logistics: Submarket Forecast ($bn), 2015-2025
  • Table 4.11: Italian Clinical Trial Supply and Logistics: Submarket Forecast ($bn), 2015-2025
  • Table 4.12: Spanish Clinical Trial Supply and Logistics: Submarket Forecast ($bn), 2015-2025
  • Table 4.13: Japanese Clinical Trial Supply and Logistics: Submarket Forecast ($bn), 2015-2025
  • Table 4.14: Selected Clinical Trial Logistics Investments in Latin America, 2012-2014
  • Table 4.15: Brazilian Clinical Trial Supply and Logistics: Submarket Forecast ($bn), 2015-2025
  • Table 4.16: Russian Clinical Trial Supply and Logistics: Submarket Forecast ($bn), 2015-2025
  • Table 4.17: Indian Clinical Trial Supply and Logistics: Submarket Forecast ($bn), 2015-2025
  • Table 4.18: Selected Clinical Trial Logistics Investments in China, 2011-2014
  • Table 4.19: Chinese Clinical Trial Supply and Logistics: Submarket Forecast ($bn), 2015-2025
  • Table 5.1: ICH Manufacturing Guidelines, 2001-2012
  • Table 6.1: Clinical Trial Supply and Logistics Market: Strengths and Weaknesses, 2013
  • Table 6.2: Clinical Trial Supply and Logistics Market: Opportunities and Threats, 2015-2025
  • Table 6.3: Clinical Trial Supply and Logistics Market: STEP Analysis, 2015-2025
  • Table 6.4: Commonwealth of Independent States: Registered Clinical Trials, 2014
  • Table 6.5: Comparative Costs of Orphan and Non-Orphan Clinical Trials, 2014
  • Table 6.6: TransCelerate BioPharma Member Companies, 2014
  • Table 6.7: The Benefits of Advanced Forecasting Tools for Clinical Trial Logistics
  • Table 6.8: Selected Clinical Trial Supply Forecasting Tools Available, 2014
  • Table 6.9: Selected IVRS/IWRS Tools Available for Clinical Trials, 2014
  • Table 6.10: Home-Based Clinical Trial Distribution: Advantages and Disadvantages, 2014
  • Table 6.11: Outsourcing Clinical Trial Supply and Logistics: Benefits and Weaknesses, 2014
  • Table 7.1: Top Ten Prescription Drugs: Overall Biologics Share, 2013 and 2019
  • Table 7.2: Leading Providers of RFID Tags for the Pharmaceutical Market, 2014
  • Table 8.1: AmerisourceBergen: Other Service Revenue ($bn) by Company, 2013
  • Table 8.2: DHL Supply Chain: Revenue ($bn) by Sector, 2013
  • Table 8.3: Marken: Revenue ($bn), 2009-2013
  • Table 8.4: Catalent: Development and Clinical Services Facilities, 2014
  • Table 8.5: Catalent Development and Clinical Services: Revenue ($bn), 2010-2013
  • Table 8.6: Patheon Pharmaceutical Development Services: Revenue ($bn), 2010-2013
  • Table 8.7: Almac Group: Revenue ($bn), 2010-2013
  • Table 8.8: Parexel: Clinical Research Services Revenue ($bn), 2010-2013
  • Table 10.1: Clinical Trial Supply and Logistics Market: Revenue ($bn) and Market Share (%) by Sector, 2013, 2019 and 2025
  • Table 10.2: Clinical Trial Supply and Logistics Market: Revenue ($bn) and Market Share (%) by Region, 2013, 2019 and 2025

List of Figures

  • Figure 2.1: Sectors and Services in the Clinical Trial Supply and Logistics Market, 2014
  • Figure 2.2: Clinical Trials Registered by Country/Region, 2014
  • Figure 2.3: Trends Affecting the Clinical Trial Supply and Logistics Market, 2015-2025
  • Figure 3.1: Pharma R&D Outsourcing Market: Market Share (%) by Sector, 2013
  • Figure 3.2: Clinical Trial Supply and Logistics Market: Market Share (%) by Sector, 2013
  • Figure 3.3: Clinical Trial Supply and Logistics Market Forecast ($bn), 2015-2025
  • Figure 3.4: Clinical Trial Supply and Logistics Market: Submarket Shares (%), 2019
  • Figure 3.5: Clinical Trial Supply and Logistics Market: Submarket Shares (%), 2025
  • Figure 3.6: Clinical Trial Supply and Logistics: Market Drivers, 2015-2025
  • Figure 3.7: Clinical Trial Supply and Logistics: Market Restraints, 2015-2025
  • Figure 3.8: Clinical Trial Manufacturing Submarket: Sector Shares (%), 2013
  • Figure 3.9: Clinical Trial Manufacturing Submarket Forecast ($bn), 2015-2025
  • Figure 3.10: Clinical Trial Manufacturing: Submarket Drivers and Restraints, 2015-2025
  • Figure 3.11: Clinical Trial Packaging Submarket Forecast ($bn), 2015-2025
  • Figure 3.12: Clinical Trial Logistics and Distribution Submarket: Sector Shares (%), 2013
  • Figure 3.13: Clinical Trial Logistics and Distribution Submarket Forecast ($bn), 2015- 2025
  • Figure 3.14: Clinical Trial Logistics and Distribution: Submarket Drivers and Restraints, 2015-2025
  • Figure 3.15: Clinical Trial Cold Chain Logistics Submarket Forecast ($bn), 2015-2025
  • Figure 3.16: Clinical Trial Supply Chain Management Submarket Forecast ($bn), 2015-2025
  • Figure 3.17: Clinical Trial Supply Chain Management: Submarket Drivers and Restraints, 2015-2025
  • Figure 4.1: Clinical Trial Supply and Logistics Market: Market Share (%) by Country/Region, 2013
  • Figure 4.2: Clinical Trial Supply and Logistics Market: Market Share (%) by Country/Region, 2013-2025
  • Figure 4.3: US Clinical Trial Supply and Logistics: Submarket Drivers and Restraints, 2015-2025
  • Figure 4.4: US Clinical Trial Supply and Logistics Submarket Forecast ($bn), 2015-2025
  • Figure 4.5: US Clinical Trial Supply and Logistics Market Share (%), 2015-2025
  • Figure 4.6: Western European Clinical Trial Supply and Logistics: Overall Forecast ($bn), 2015-2025
  • Figure 4.7: Western European Clinical Trial Supply and Logistics Market Share (%), 2015-2025
  • Figure 4.8: Western European Clinical Trial Supply and Logistics: Submarket Drivers and Restraints, 2015-2025
  • Figure 4.9: Western European Clinical Trial Supply and Logistics Submarket Shares (%) by Top Country, 2013
  • Figure 4.10: German and French Clinical Trial Supply and Logistics: Submarket Forecasts ($bn), 2015-2025
  • Figure 4.11: UK, Italian and Spanish Clinical Trial Supply and Logistics Submarket Forecasts ($bn), 2015-2025
  • Figure 4.12: Japanese Clinical Trial Supply and Logistics Submarket Forecast ($bn), 2015-2025
  • Figure 4.13: Japanese Clinical Trial Supply and Logistics Market Share (%), 2015-2025
  • Figure 4.14: Japanese Clinical Trial Supply and Logistics: Submarket Drivers and Restraints, 2015-2025
  • Figure 4.15: Brazilian Clinical Trial Supply and Logistics Submarket Forecast ($bn), 2015-2025
  • Figure 4.16: Brazilian Clinical Trial Supply and Logistics Market Share (%), 2015-2025
  • Figure 4.17: Brazilian Clinical Trial Supply and Logistics: Submarket Drivers and Restraints, 2015-2025
  • Figure 4.18: Russian Clinical Trial Supply and Logistics Submarket Forecast ($bn), 2015-2025
  • Figure 4.19: Russian Clinical Trial Supply and Logistics Market Share (%), 2015-2025
  • Figure 4.20: Russian Clinical Trial Supply and Logistics: Submarket Drivers and Restraints, 2015-2025
  • Figure 4.21: Indian Clinical Trial Supply and Logistics Submarket Forecast ($bn), 2015-2025
  • Figure 4.22: Indian Clinical Trial Supply and Logistics Market Share (%), 2015-2025
  • Figure 4.23: Indian Clinical Trial Supply and Logistics: Submarket Drivers and Restraints, 2015-2025
  • Figure 4.24: Chinese Clinical Trial Supply and Logistics: Submarket Forecast ($bn), 2015-2025
  • Figure 4.25: Chinese Clinical Trial Supply and Logistics: Submarket Drivers and Restraints, 2015-2025
  • Figure 4.26: Chinese Clinical Trial Supply and Logistics Market Share (%), 2015-2025
  • Figure 6.1: Players in the Clinical Trial Supply Chain, 2014
  • Figure 7.1: World Pharmaceutical Market Forecast by Drug Type, 2013 and 2019
  • Figure 8.1: AmerisourceBergen: Other Service Revenue Share (%) by Company, 2013
  • Figure 8.2: DHL Supply Chain: Revenue Share (%) by Sector, 2013
  • Figure 8.3: Marken: Revenue ($bn), 2009-2013
  • Figure 8.4: Catalent: Clinical Manufacturing Space by Region (%), 2014
  • Figure 8.5: Catalent Development and Clinical Services: Revenue ($bn), 2010-2013
  • Figure 8.6: Patheon Pharmaceutical Development Services: Revenue ($bn), 2010-2013
  • Figure 8.7: Almac Group: Revenue ($bn), 2010-2013
  • Figure 8.8: Parexel: Clinical Research Services Revenue ($bn), 2010-2013
  • Figure 10.1: Clinical Trial Supply and Logistics Market: Revenue ($bn) by Sector, 2013, 2019 and 2025
  • Figure 10.2: Clinical Trial Supply and Logistics Market: Revenue ($bn) by Region, 2013, 2019 and 2025

Companies Listed

  • AbbVie Contract Pharmaceutical Manufacturing
  • ABCS
  • ACM Global Central Lab
  • Agência Nacional de Vigilância Sanitária (ANVISA)
  • Allergan
  • Almac Group
  • AmerisourceBergen
  • AndersonBrecon
  • Aptuit
  • Astellas Pharma
  • AstraZeneca
  • Bellwyck Packaging Solutions
  • BioClinica
  • Biogen Idec
  • Biotec Services International
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • British Telecom (BT)
  • CAEN RFID
  • Cardinal Systems
  • Catalent Pharma Solutions
  • Celesio
  • Cenduit
  • Central Drugs Standard Control Organization (CDSCO)
  • China FDA (CFDA)
  • Chinese Ministry of Health
  • ClinIntel
  • ClinStar
  • Comissão Nacional de Ética em Pesquisa (CONEP)
  • Consorcio de Apoyo a la Investigación Biomédica - Plataforma Española de Ensayos Clínicos (CAIBER)
  • COREX
  • Cortec
  • Cryoport
  • Cubist Pharmaceuticals
  • DHL
  • Drug Controller General of India (DCGI)
  • Eli Lilly
  • European Medicines Agency (EMA)
  • EPS
  • e-Trial Co.
  • European Commission
  • Eurodifarm
  • Food and Drug Administration (FDA)
  • Federal Express (FedEx)
  • Fisher Clinical Services
  • Frazier Healthcare
  • GE Healthcare
  • Greenbox
  • International Business Machines (IBM)
  • ICON
  • IMP Logistics
  • Infosys
  • Intelleflex
  • Intelsius
  • International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH)
  • International Air Transport Association (IATA)
  • International Pharmaceutical Federation
  • Japanese Ministry of Health, Labour and Welfare (MHLW)
  • Johnson & Johnson
  • Komtur Pharmaceuticals
  • LabCorp
  • LCAG USA
  • LifeConEx
  • Lonza
  • Marken
  • Mawdsleys
  • Medgenics
  • Medicines and Healthcare Products Regulatory Agency (MHRA)
  • Merck Serono
  • Mitsui & Co.
  • Movianto
  • National Institutes of Health (NIH)
  • NextPharma
  • Novo Nordisk
  • Novotech
  • N-SIDE
  • Nuvilex
  • Octapharma
  • Owens&Minor
  • Parexel
  • Patheon
  • Packaging Coordinators Inc. (PCI)
  • Perceptive Informatics
  • Pfizer
  • Pharmaceuticals for Human Use (ICH)
  • Pieffe Group
  • PRA International
  • Quintiles
  • Recipharm
  • Roche
  • Sanofi
  • SF Express
  • Shionogi
  • SIRO Clinpharm
  • TheraCom
  • Thermo Fisher Scientific
  • TNT Express
  • TransCelerate BioPharma
  • Transportation Administration Security (TAS)
  • Tufts Center
  • UCB
  • United Parcel Service (UPS)
  • US Pharmacopeia (USP)
  • Vsoft Infoware
  • World Courier
  • World Health Organization (WHO)
  • Worldwide Clinical Trials
  • Y Prime
Back to Top